At the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, Johnson & Johnson MedTech unveiled a series of pioneering innovations set to revolutionize orthopaedic surgery. With a history of more than 135 years of medical innovation, the company unveiled its new implants, robotic platforms, and AI-based solutions aimed at improving precision, efficiency, and patient outcomes.
VELYS™ Robotic-Assisted Solution.
One of the highlights was the VELYS Robotic-Assisted Solution, a digital, CT-free platform that has already supported more than 100,000 knee replacement surgeries in 31 countries. The U.S. FDA recently approved VELYS™ for unicompartmental knee arthroplasty (UKA), its first indication beyond partial knee replacement. When used with the ATTUNE™ Knee System, studies indicate a 33% reduced risk of revision, enhancing long-term patient results.
The VELYS Robotic-Assisted Solution is transforming orthopedic surgery by enhancing precision, efficiency, and patient outcomes, as demonstrated at AAOS 2025.
KINCISE™ 2 Surgical System.
To address surgeons’ physical strain during joint replacements, Johnson & Johnson introduced the KINCISE™ 2 Surgical Automated System. This advanced power tool provides automation and greater control, minimizing surgeon fatigue and improving surgical accuracy and efficiency.
VELYS™ Active Robotic Assistance for Spine Surgery.
The firm also launched the VELYS™ Active Robotic Assistance Solution for spine procedures. Co-designed with leading spine surgeons, this technology integrates real-time navigation and robotic assistance for precise and flexible spinal surgery With millions of spinal surgeries carried out each year, this innovation hopes to enhance safety and efficiency.
VOLT™ Trauma System Expansion.
The VOLT Plating System, with its dynamic compression feature, was granted European CE Marking after FDA clearance and U.S. market entry. To be launched in a few select European markets in 2025, it improves fracture fixation with a combination of stability and flexibility.
INHANCE INTACT Shoulder Replacement.
The FDA-cleared INHANCE™ INTACT™ system allows subscapularis-sparing shoulder surgery, enabling immediate postoperative mobilization without the standard six-week immobilization. Coupled with 3D pre-surgical planning, this technology tailors treatment for improved patient recovery.
AI-Powered Advance Case Management System.
The AI-powered Advance Case Management system optimizes pre-surgical workflows, boosting efficiency in ambulatory centers and outpatient facilities.
Johnson & Johnson MedTech advances orthopedic surgery toward a future of greater precision, efficiency, and patient care.
Reference: Johnson & Johnson MedTech showcases new orthopedic offerings
